Orion OYJ (OTCMKTS:ORINY) Hits New 12-Month High – Here’s What Happened

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $46.11 and last traded at $46.00, with a volume of 847 shares trading hands. The stock had previously closed at $46.00.

Orion OYJ Price Performance

The company has a quick ratio of 1.48, a current ratio of 2.64 and a debt-to-equity ratio of 0.08. The stock’s 50-day simple moving average is $43.45 and its two-hundred day simple moving average is $40.29. The company has a market capitalization of $13.31 billion, a price-to-earnings ratio of 19.41 and a beta of 0.08.

Orion OYJ (OTCMKTS:ORINY) last announced its earnings results on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The business had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%.

Orion OYJ Company Profile

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.